IgM Deficiency in Autoimmune Blistering Mucocutaneous Diseases Following Various Treatments: Long Term Follow-Up and Relevant Observations

IgM Deficiency in Autoimmune Blistering Mucocutaneous Diseases Following Various Treatments: Long Term Follow-Up and Relevant Observations

Link to original article: https://www.frontiersin.org/articles/10.3389/fimmu.2021.727520/full A. Razzaque Ahmed1,2* and Merve Aksoy1 1Department of Dermatology, The Center for Blistering Diseases, Tufts University School of Medicine, Boston, MA, United States 2Dermatology Service, Boston Veterans Administration Health Services, Boston, MA, United States IgM deficiency has been reported in patients with many autoimmune diseases treated with Rituximab (RTX). It has not …

IgM Deficiency in Autoimmune Blistering Mucocutaneous Diseases Following Various Treatments: Long Term Follow-Up and Relevant Observations Read More »